GitLab Cl A saw its IBD SmartSelect Composite Rating jump to 97 Friday, up from 91 the day before.
The new score means the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria. The market's biggest winners often have a 95 or higher score in the early stages of a new price run, so that's an important benchmark to look for when looking for the best stocks to buy and watch.
GitLab Cl A is not currently near a proper entry. See if the stock goes on to form a new base and offer a new buying opportunity.
Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets
The stock sports an 81 EPS Rating, which means its recent quarterly and longer-term annual earnings growth tops 81% of all stocks.
Its Accumulation/Distribution Rating of B- shows moderate buying by institutional investors over the last 13 weeks.
In Q3, the company reported 156% earnings growth. Top line growth was flat, matching the prior report's 31%. The company's next quarterly report is expected on or around Mar. 3.
GitLab Cl A earns the No. 4 rank among its peers in the Computer-Technical Services industry group. IBEX is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
